Connect with us

Hi, what are you looking for?

Wednesday, Mar 11, 2026

Mugglehead Investment Magazine

Alternative investment news based in Vancouver, B.C.

Mugglehead Investment Magazine

All posts tagged "Clostridioides difficile infection"

Acurx Pharma shares rise by 29% after launching trial for breakthrough antibiotic 'Ibezapolstat'

Acurx Pharma shares rise by 29% after launching trial for breakthrough antibiotic 'Ibezapolstat'

Medical and Pharmaceutical

Acurx Pharma shares rise by 29% on new trial for breakthrough antibiotic ‘ibezapolstat’

Investors are optimistic about the therapeutic's potential as a superior alternative for CDI treatment

Rowan Dunne4 hours ago

More Posts